Literature DB >> 7581368

A widespread amino acid polymorphism at codon 905 of the glycogen-associated regulatory subunit of protein phosphatase-1 is associated with insulin resistance and hypersecretion of insulin.

L Hansen1, T Hansen, H Vestergaard, C Bjørbaek, S M Echwald, J O Clausen, Y H Chen, M X Chen, P T Cohen, O Pedersen.   

Abstract

The regulatory G-subunit of the glycogen-associated form of protein phosphatase 1 (PP1) plays a crucial part in muscle tissue glycogen synthesis and breakdown. As impaired insulin stimulated glycogen synthesis in peripheral tissues is considered to be a pathogenic factor in subsets of non-insulin-dependent diabetes mellitus (NIDDM) and obesity, the G-subunit of PP1 should be viewed as a candidate gene for inherited insulin resistance. When applying heteroduplex formation analysis and nucleotide sequencing of PP1G-subunit cDNA from 30 insulin resistant white NIDDM patients two cases were identified as heterozygous carriers of an Asp905 --> Tyr substitution. The carrier prevalence of the PP1G-subunit variant was 18% in 150 healthy subjects and 13% in 313 NIDDM subjects (chi 2 = 1.94, p = 0.16). Twenty-seven healthy subjects volunteered for a 4 h euglycaemic, hyperinsulinaemic clamp in combination with indirect calorimetry in order to elucidate the potential impact of the Tyr905 substitution on the whole body glucose metabolism. Interestingly, the Tyr905 variant was associated with altered routing of glucose: a decreased insulin stimulated non-oxidative glucose metabolism of peripheral tissues (glycogen synthesis) (p < 0.04) and an increased basal glucose oxidation rate (p < 0.04) when compared with wild type carriers. A population-based sample of 380 unrelated young healthy Caucasians was examined during a combined intravenous glucose and tolbutamide test to address whether the Asp905/Tyr905 polymorphism was associated with alterations in insulin secretion which might be secondary to the insulin resistance of skeletal muscle.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7581368     DOI: 10.1093/hmg/4.8.1313

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  18 in total

1.  Tissue glycogen content and glucose intolerance.

Authors:  Masato Kasuga; Wataru Ogawa; Takeshi Ohara
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

Review 2.  Genetics of diabetes.

Authors:  Richard B Horenstein; Alan R Shuldiner
Journal:  Rev Endocr Metab Disord       Date:  2004-03       Impact factor: 6.514

3.  The Val985Met insulin-receptor variant in the Danish Caucasian population: lack of associations with non-insulin-dependent diabetes mellitus or insulin resistance.

Authors:  L Hansen; T Hansen; J O Clausen; S M Echwald; S A Urhammer; S K Rasmussen; O Pedersen
Journal:  Am J Hum Genet       Date:  1997-06       Impact factor: 11.025

4.  Whole-exome sequencing in maya indigenous families: variant in PPP1R3A is associated with type 2 diabetes.

Authors:  Katy Sánchez-Pozos; María Guadalupe Ortíz-López; Bárbara I Peña-Espinoza; María de Los Ángeles Granados-Silvestre; Verónica Jiménez-Jacinto; Jérôme Verleyen; Fasil Tekola-Ayele; Alejandro Sanchez-Flores; Marta Menjivar
Journal:  Mol Genet Genomics       Date:  2018-06-11       Impact factor: 3.291

Review 5.  Protein phosphatase-1 and insulin action.

Authors:  L Ragolia; N Begum
Journal:  Mol Cell Biochem       Date:  1998-05       Impact factor: 3.396

6.  Differential methylation of genes in individuals exposed to maternal diabetes in utero.

Authors:  Peng Chen; Paolo Piaggi; Michael Traurig; Clifton Bogardus; William C Knowler; Leslie J Baier; Robert L Hanson
Journal:  Diabetologia       Date:  2017-01-26       Impact factor: 10.122

Review 7.  Regulation of Glucose Production in the Pathogenesis of Type 2 Diabetes.

Authors:  Ashot Sargsyan; Mark A Herman
Journal:  Curr Diab Rep       Date:  2019-08-03       Impact factor: 4.810

8.  Association of genetic variants in INS (rs689), INSR (rs1799816) and PP1G.G (rs1799999) with type 2 diabetes (T2D): a case-control study in three ethnic groups from North-West India.

Authors:  Jasmine Sokhi; Ruhi Sikka; Priyanka Raina; Ramandeep Kaur; Kawaljit Matharoo; Punit Arora; Ajs Bhanwer
Journal:  Mol Genet Genomics       Date:  2015-08-07       Impact factor: 3.291

9.  Genetic variability in the insulin signalling pathway may contribute to the risk of late onset Alzheimer's disease.

Authors:  D Liolitsa; J Powell; S Lovestone
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-09       Impact factor: 10.154

Review 10.  The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes.

Authors:  S E Kahn
Journal:  Diabetologia       Date:  2003-01-11       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.